EGFR and cancer: The epidermal growth factor receptor (EGFR) overexpresses and activates the downstream phosphoinositide 3-kinase-AKT and mitogen-activated protein kinase-extracellular signal-regulated kinase (ERK; MEK) signaling pathways, respectively, thus regulating the survival and proliferation of cancer cells [1,2].